203 related articles for article (PubMed ID: 33650343)
1. The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
Tokunaga H; Mikami M; Nagase S; Kobayashi Y; Tabata T; Kaneuchi M; Satoh T; Hirashima Y; Matsumura N; Yokoyama Y; Kawana K; Kyo S; Aoki D; Katabuchi H
J Gynecol Oncol; 2021 Mar; 32(2):e49. PubMed ID: 33650343
[TBL] [Abstract][Full Text] [Related]
2. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer.
Komiyama S; Katabuchi H; Mikami M; Nagase S; Okamoto A; Ito K; Morishige K; Suzuki N; Kaneuchi M; Yaegashi N; Udagawa Y; Yoshikawa H
Int J Clin Oncol; 2016 Jun; 21(3):435-46. PubMed ID: 27142770
[TBL] [Abstract][Full Text] [Related]
3. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
4. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
Berek JS; Renz M; Kehoe S; Kumar L; Friedlander M
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):61-85. PubMed ID: 34669199
[TBL] [Abstract][Full Text] [Related]
5. Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E
J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853
[TBL] [Abstract][Full Text] [Related]
6. [Clinical recommendations for diagnosing, treatment and monitoring of patients with ovarian cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology].
Matković V; Haller H; Vrdoljak E; Corusić A; Jelavić TB; Strinić T; Karnjus-Begonja R; Barisic D; Tomić S; Kukura V; Ban M; Ranka SP; Matic M; Skalec SL; Topolovec Z; Mrcela M; Zekan J; Fröbe A; Hajredini A; Babic D; Mamula O; Brncić-Fischer A; Vojnović Z; Sundov D; ; ;
Lijec Vjesn; 2013; 135(9-10):235-41. PubMed ID: 24364199
[TBL] [Abstract][Full Text] [Related]
7. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Armstrong DK; Alvarez RD; Bakkum-Gamez JN; Barroilhet L; Behbakht K; Berchuck A; Chen LM; Cristea M; DeRosa M; Eisenhauer EL; Gershenson DM; Gray HJ; Grisham R; Hakam A; Jain A; Karam A; Konecny GE; Leath CA; Liu J; Mahdi H; Martin L; Matei D; McHale M; McLean K; Miller DS; O'Malley DM; Percac-Lima S; Ratner E; Remmenga SW; Vargas R; Werner TL; Zsiros E; Burns JL; Engh AM
J Natl Compr Canc Netw; 2021 Feb; 19(2):191-226. PubMed ID: 33545690
[TBL] [Abstract][Full Text] [Related]
8. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
9. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():214-223. PubMed ID: 30905627
[TBL] [Abstract][Full Text] [Related]
10. [Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)].
Lavoué V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lécuru F; Lefrère-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Sénéchal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):100-110. PubMed ID: 30686724
[TBL] [Abstract][Full Text] [Related]
11. Trends in ovarian, fallopian tube, and primary peritoneal cancer incidence, mortality, and survival: A 15-year population-based analysis.
Somasegar S; Reddy RA; Chow S; Dorigo O; Renz M; Karam A
Gynecol Oncol; 2024 May; 184():190-197. PubMed ID: 38330833
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Coleman RL; Brady MF; Herzog TJ; Sabbatini P; Armstrong DK; Walker JL; Kim BG; Fujiwara K; Tewari KS; O'Malley DM; Davidson SA; Rubin SC; DiSilvestro P; Basen-Engquist K; Huang H; Chan JK; Spirtos NM; Ashfaq R; Mannel RS
Lancet Oncol; 2017 Jun; 18(6):779-791. PubMed ID: 28438473
[TBL] [Abstract][Full Text] [Related]
13. Cancer of the ovary, fallopian tube, and peritoneum.
Berek JS; Kehoe ST; Kumar L; Friedlander M
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():59-78. PubMed ID: 30306591
[TBL] [Abstract][Full Text] [Related]
14. Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Kerliu L; Myruski S; Bhatti A; Soni P; Petrosius P; Pervanas HC; Horton ER
Ann Pharmacother; 2020 Oct; 54(10):1010-1015. PubMed ID: 32172572
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Cohn DE; Sill MW; Walker JL; O'Malley D; Nagel CI; Rutledge TL; Bradley W; Richardson DL; Moxley KM; Aghajanian C
Gynecol Oncol; 2017 Sep; 146(3):477-483. PubMed ID: 28756871
[TBL] [Abstract][Full Text] [Related]
16. Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Koole S; van Stein R; Sikorska K; Barton D; Perrin L; Brennan D; Zivanovic O; Mosgaard BJ; Fagotti A; Colombo PE; Sonke G; Driel WJV;
Int J Gynecol Cancer; 2020 Jun; 30(6):888-892. PubMed ID: 32205449
[TBL] [Abstract][Full Text] [Related]
17. Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
Suh DH; Chang SJ; Song T; Lee S; Kang WD; Lee SJ; Roh JW; Joo WD; Yoon JH; Jeong DH; Kim HS; Lee SJ; Ji YI; Kim HJ; Lee JW; Kim JW; Bae DS
J Gynecol Oncol; 2018 Jul; 29(4):e56. PubMed ID: 29770626
[TBL] [Abstract][Full Text] [Related]
18. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.
Rauh-Hain JA; Foley OW; Winograd D; Andrade C; Clark RM; Vargas RJ; Hinchcliff EM; Esselen KM; Horowitz NS; del Carmen MG
Am J Obstet Gynecol; 2015 May; 212(5):600.e1-8. PubMed ID: 25514761
[TBL] [Abstract][Full Text] [Related]
20. Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases.
Maeda D; Ota S; Takazawa Y; Ohashi K; Mori M; Imamura T; Nakagawa S; Yano T; Taketani Y; Fukayama M
Virchows Arch; 2010 Nov; 457(5):597-608. PubMed ID: 20872013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
